The Nirali Memorial Medical Trust (NMMT), founded by Mr. A.M. Naik, Group Chairman, L&T, will set up a speciality cancer hospital at Navsari, Gujarat, and the Tata Trusts will manage the operations of the facility. On July 11, 2018, an agreement to this effect was signed between Nirali Memorial Medical Trust and the Tata Trusts, in the presence of Mr. A.M. Naik and Mr. Ratan N. Tata.
The mission of the proposed hospital at Navsari is to benefit the needy sections of society in their fight against cancer. Speaking at the occasion, Mr. A.M. Naik said, “Availability of modern health care facilities is a prerequisite for social progress and well-being. The Nirali Memorial Medical Trust is committed to bringing the benefits of advanced medical treatment to all sections of the society. Nirali Memorial Medical Trust’s initiatives are helping needy patients, especially from disadvantaged sections of the society, to get the best care at an affordable cost. The Tata Trusts are well respected across India for their path breaking initiatives in the field of cancer care and I am delighted with this partnership between Nirali Memorial Medical Trust and the Tata Trusts for setting up a speciality cancer hospital at Navsari.”
Lauding the initiative, Mr. Ratan N. Tata commented, “Cancer needs to be tackled on a war footing. Mr. Naik’s initiative, which should be emulated, will go a long way in making cancer care affordable and accessible.”
NMMT will create the hospital infrastructure with advanced facilities and install state-of-the-art equipment while Tata Trusts will be responsible for patient care and day-to-day operations. The comprehensive cancer care hospital at Navsari will have facilities that range from clinical Pathology, High-end Linear Accelerator, Histopathology, Biochemistry, USG, Digital X-Ray and Mammography to CT simulators, Brachytherapy OPDs as well as major Operation Theatres. The upcoming centre will also be a part of the overall network of cancer centres being established by the Tata Trusts across the country.